CLOS
TNDM icon

Compagnie Lombard Odier SCmA’s Tandem Diabetes Care TNDM Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-670
Closed -$65K – 679
2021
Q2 		$65K Sell
670
-228,331
-100% -$20.4M ﹤0.01% 460
2021
Q1 		$20.2M Buy
+229,001
New +$21.3M 0.45% 49

Other funds holding TNDM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Compagnie Lombard Odier SCmA's TNDM Position: Q3 2021 in Review

Compagnie Lombard Odier SCmA sold out of Tandem Diabetes Care (TNDM) in Q3 2021, closing a stake of 670 shares — an estimated $65K sold.

Compagnie Lombard Odier SCmA first reported a position in TNDM in Q1 2021 and held it in 2 quarters. The position peaked at $20.2M in Q1 2021. 337 funds tracked by Wall St. Rank hold TNDM as of Q3 2021.

  • Compagnie Lombard Odier SCmA reported no remaining Tandem Diabetes Care position as of Q3 2021 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 670 Tandem Diabetes Care shares in Q3 2021, an estimated $65K.
  • Compagnie Lombard Odier SCmA first reported a position in Tandem Diabetes Care in Q1 2021 and held it in 2 quarters.
  • Compagnie Lombard Odier SCmA's Tandem Diabetes Care position peaked at $20.2M in Q1 2021.
  • 337 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2021.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q3 2021, filed 28 Oct 2021.